Your browser doesn't support javascript.
loading
Correlation of Soluble CD44 Expression in Saliva and CD44 Protein in Oral Leukoplakia Tissues.
Cema, Ingrida; Dzudzilo, Madara; Kleina, Regina; Franckevica, Ivanda; Svirskis, Simons.
Afiliação
  • Cema I; Department of Oral Medicine, Riga Stradins University, 16 Dzirciema Str., LV-1007 Riga, Latvia.
  • Dzudzilo M; Doctoral Study Department, Riga Stradins University, 16 Dzirciema Str., LV-1007 Riga, Latvia.
  • Kleina R; Department of Pathology, Riga Stradins University, 16 Dzirciema Str., LV-1007 Riga, Latvia.
  • Franckevica I; Department of Pathology, Children's Clinical University Hospital, Vienibas Gatve 45, LV-1004 Riga, Latvia.
  • Svirskis S; Institute of Microbiology and Virology, Riga Stradins University, 5 Ratsupites Str., LV-1067 Riga, Latvia.
Cancers (Basel) ; 13(22)2021 Nov 16.
Article em En | MEDLINE | ID: mdl-34830890
ABSTRACT
The aim of this study was to determine whether and how pan-CD44 protein expression in leukoplakia tissues correlates with positive SolCD44 test presence and their role in oral leukoplakia. SolCD44 and total protein expression in saliva were determined using an OncAlert® Oral Cancer Rapid test. Comparison of paired associations of total protein, SolCD44, mean number of CD44 expressed epithelial layers in leukoplakia tissue, and macrophages below the basement membrane between control group and patients with leukoplakia showed statistically significant results (p < 0.0001). It is shown that the total protein indicates low or elevated risk of possible malignant transformation processes in leukoplakia. Statistically significant differences between higher total protein level and clinical forms of oral leukoplakia (p < 0.0001), as well as CD44-labeled epithelial cell layer decrease (p < 0.0001), were found. This possibly points to the onset of the stemness loss in leukoplakia tissue. CD9 antigen expression in the exosomes of the oral epithelium explained the intercellular flow of SolCD44 and other fluids in the leukoplakia area. We conclude that the OncAlert® Oral Cancer Rapid test is a valuable screening method in daily clinical practice, in terms of complementing clinical diagnostics methods and to assess the potential for early malignancy.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article